Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

OTR Global Upgrades Burlington Stores to Positive

OTR Global upgrades Burlington Stores (NYSE:BURL) from Mixed to Positive.

byBenzinga Newsdesk

February 1, 2023

1 minute read

OTR Global upgrades Burlington Stores (NYSE:BURL) from Mixed to Positive.

Dow Announces Strategic Collaboration With Natura For Project Ybá In Brazil

By Benzinga Newsdesk

Today, 2:48 AM

https://corporate.dow.com/en-us/news/press-releases/dow-announces-strategic-collaboration-with-natura

DOW

Cantor Fitzgerald Initiates Coverage On Magenta Therapeutics with Overweight Rating, Announces Price Target of $20

By Benzinga Newsdesk

Today, 2:48 AM

Cantor Fitzgerald analyst Emma Nealon initiates coverage on Magenta Therapeutics (NASDAQ:MGTA) with a Overweight rating and announces Price Target of $20.

MGTA

RBC Capital Maintains Outperform on George Weston, Raises Price Target to C$154

By Benzinga Newsdesk

Today, 2:48 AM

RBC Capital analyst Irene Nattel maintains George Weston (TSX:WN) with a Outperform and raises the price target from C$150 to C$154.

TSX:WN

EXCLUSIVE: Alzamend Neuro Partners With Stem Cell Institute For Immunotherapy Vaccine Trial For Dementia

By Vandana Singh

Today, 2:48 AM

Alzamend Neuro Inc (NASDAQ: ALZN) has partnered with the Miller School of Medicine, Interdisciplinary Stem Cell Institute at the University of Miami for its Phase 1/2A trial of ALZN002.

ALZN

OTR Global Upgrades Burlington Stores to Positive

Related Posts

Dow Announces Strategic Collaboration With Natura For Project Ybá In Brazil

Cantor Fitzgerald Initiates Coverage On Magenta Therapeutics with Overweight Rating, Announces Price Target of $20

RBC Capital Maintains Outperform on George Weston, Raises Price Target to C$154

EXCLUSIVE: Alzamend Neuro Partners With Stem Cell Institute For Immunotherapy Vaccine Trial For Dementia